Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
363 | 3 | RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN II//BRADYKININ | 35741 |
154 | 2 | RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN II//ANGIOTENSINOGEN | 22449 |
11939 | 1 | TELMISARTAN//ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER//OBES EDUC INITIAT | 971 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | TELMISARTAN | authKW | 844107 | 14% | 19% | 136 |
2 | ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER | authKW | 122020 | 2% | 20% | 19 |
3 | OBES EDUC INITIAT | address | 115392 | 1% | 44% | 8 |
4 | CLIN TRIAL MANAGEMENTITABASHI KU | address | 97370 | 0% | 100% | 3 |
5 | RENIN ANGIOTENSIN SYSTEM | authKW | 81857 | 10% | 3% | 99 |
6 | ANGIOTENSINOGEN EXPRESSION | authKW | 64913 | 0% | 100% | 2 |
7 | COEXISTENT TYPE TWO DIABETES MELLITUS AND HYPERTENSION | authKW | 64913 | 0% | 100% | 2 |
8 | FRANZ VOLHARD CLIN CHARITE | address | 64913 | 0% | 100% | 2 |
9 | TREATMENT FOR COEXISTENT TYPE TWO DIABETES MELLITUS AND HYPERTENSION | authKW | 64913 | 0% | 100% | 2 |
10 | MUSCLE METAB | address | 63624 | 1% | 20% | 10 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 7741 | 26% | 0% | 256 |
2 | Endocrinology & Metabolism | 5062 | 28% | 0% | 274 |
3 | Pharmacology & Pharmacy | 583 | 16% | 0% | 159 |
4 | Physiology | 436 | 8% | 0% | 79 |
5 | Cardiac & Cardiovascular System | 424 | 9% | 0% | 91 |
6 | Medicine, Research & Experimental | 204 | 7% | 0% | 64 |
7 | Nutrition & Dietetics | 170 | 4% | 0% | 40 |
8 | Urology & Nephrology | 57 | 3% | 0% | 29 |
9 | Medicine, General & Internal | 56 | 5% | 0% | 51 |
10 | Cell Biology | 16 | 4% | 0% | 42 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | OBES EDUC INITIAT | 115392 | 1% | 44% | 8 |
2 | CLIN TRIAL MANAGEMENTITABASHI KU | 97370 | 0% | 100% | 3 |
3 | FRANZ VOLHARD CLIN CHARITE | 64913 | 0% | 100% | 2 |
4 | MUSCLE METAB | 63624 | 1% | 20% | 10 |
5 | MOL CARDIOVASC BIOL PHARMACOL | 61738 | 1% | 14% | 14 |
6 | GENOM EPIDEMIOL CLIN TRIALSITABASHI KU | 48682 | 0% | 50% | 3 |
7 | BIOL DEV TISSU ADIPEUXCNRSUMR 6543 | 43274 | 0% | 67% | 2 |
8 | CNRS 6543 | 43274 | 0% | 67% | 2 |
9 | PHARMACOLITABASHI KU | 43274 | 0% | 67% | 2 |
10 | ANAT ENTWICKLUNGSBIOL | 32457 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HYPERTENSION RESEARCH | 23194 | 4% | 2% | 43 |
2 | CARDIOVASCULAR DIABETOLOGY | 4781 | 1% | 1% | 14 |
3 | HYPERTENSION | 4640 | 4% | 0% | 41 |
4 | JOURNAL OF HYPERTENSION | 4495 | 4% | 0% | 37 |
5 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 4381 | 1% | 1% | 11 |
6 | CURRENT HYPERTENSION REPORTS | 4206 | 1% | 1% | 12 |
7 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 3493 | 2% | 1% | 15 |
8 | AMERICAN JOURNAL OF HYPERTENSION | 3334 | 3% | 0% | 25 |
9 | AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2818 | 2% | 0% | 24 |
10 | CARDIORENAL MEDICINE | 2419 | 0% | 2% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |